182
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Discovery of Potential Plasma Biomarkers for Tuberculosis in HIV-Infected Patients by Data-Independent Acquisition-Based Quantitative Proteomics

ORCID Icon, , , , , , , , , , & ORCID Icon show all
Pages 1185-1196 | Published online: 24 Apr 2020

References

  • Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163(9):1009–1021. doi:10.1001/archinte.163.9.100912742798
  • Ai JW, Ruan QL, Liu QH, Zhang WH. Updates on the risk factors for latent tuberculosis reactivation and their managements. Emerg Microbes Infect. 2016;5:e10. doi:10.1038/emi.2016.1026839146
  • World Health Organization. Global tuberculosis report. 10, 2019 Available from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf. Accessed 1212, 2019.
  • Diedrich CR, Flynn JL. HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun. 2011;79(4):1407–1417. doi:10.1128/IAI.01126-1021245275
  • Schutz C, Meintjes G, Almajid F, Wilkinson RJ, Pozniak A. Clinical management of tuberculosis and HIV-1 co-infection. Eur Respir J. 2010;36(6):1460–1481. doi:10.1183/09031936.0011021020947678
  • Elliott AM, Namaambo K, Allen BW, et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis. 1993;74(3):191–194. doi:10.1016/0962-8479(93)90010-U8369514
  • Lawson L, Yassin MA, Ramsay A, Emenyonu NE, Squire SB, Cuevas LE. Comparison of scanty AFB smears against culture in an area with high HIV prevalence. Int J Tuberc Lung Dis. 2005;9(8):933–935.16104643
  • Hathout Y, Brody E, Clemens PR, et al. Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2015;112(23):7153–7158. doi:10.1073/pnas.150771911226039989
  • Duangkumpha K, Stoll T, Phetcharaburanin J, et al. Discovery and qualification of serum protein biomarker candidates for cholangiocarcinoma diagnosis. J Proteome Res. 2019;18(9):3305–3316. doi:10.1021/acs.jproteome.9b0024231310545
  • Achkar JM, Cortes L, Croteau P, et al. Host protein biomarkers identify active tuberculosis in HIV uninfected and co-infected individuals. EBioMedicine. 2015;2(9):1160–1168. doi:10.1016/j.ebiom.2015.07.03926501113
  • Xu DD, Deng DF, Li X, et al. Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics. 2014;14(2–3):322–331. doi:10.1002/pmic.20130038324339194
  • Chen C, Yan T, Liu L, Wang J, Jin Q. Identification of a novel serum biomarker for tuberculosis infection in Chinese HIV patients by iTRAQ-based quantitative proteomics. Front Microbiol. 2018;9:330. doi:10.3389/fmicb.2018.0033029535695
  • Jayakumar A, Vittinghoff E, Segal MR, et al. Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis. Tuberculosis (Edinb). 2015;95(4):415–420. doi:10.1016/j.tube.2015.04.01126022314
  • Johnson JL, Geldenhuys H, Thiel BA, et al. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB Incidence area. Chest. 2014;145(3):612–617. doi:10.1378/chest.13-123224135768
  • Ludwig C, Gillet L, Rosenberger G, Amon S, Collins BC, Aebersold R. Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial. Mol Syst Biol. 2018;14(8):e8126. doi:10.15252/msb.2017812630104418
  • Conesa A, Gotz S, Garcia-Gomez JM, Terol J, Talon M, Robles M. Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics. 2005;21(18):3674–3676. doi:10.1093/bioinformatics/bti61016081474
  • Moriya Y, Itoh M, Okuda S, Yoshizawa AC, Kanehisa M. KAAS: an automatic genome annotation and pathway reconstruction server. Nucleic Acids Res. 2007;35(WebServer issue):W182–W185. doi:10.1093/nar/gkm32117526522
  • Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K. Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. Respirology. 2018;23(7):656–673. doi:10.1111/resp.1330429641838
  • Hu A, Noble WS, Wolf-Yadlin A. Technical advances in proteomics: new developments in data-independent acquisition. F1000Res. 2016;5:419. doi:10.12688/f1000research.7042.1
  • Bruderer R, Bernhardt OM, Gandhi T, et al. Optimization of experimental parameters in data-independent mass spectrometry significantly increases depth and reproducibility of results. Mol Cell Proteomics. 2017;16(12):2296–2309. doi:10.1074/mcp.RA117.00031429070702
  • Liu Y, Huttenhain R, Collins B, Aebersold R. Mass spectrometric protein maps for biomarker discovery and clinical research. Expert Rev Mol Diagn. 2013;13(8):811–825. doi:10.1586/14737159.2013.84508924138574
  • Carlyle BC, Trombetta BA, Arnold SE. Proteomic approaches for the discovery of biofluid biomarkers of neurodegenerative dementias. Proteomes. 2018;6(3):32. doi:10.3390/proteomes6030032
  • Tong L, Tergaonkar V. Rho protein GTPases and their interactions with NFkappaB: crossroads of inflammation and matrix biology. Biosci Rep. 2014;34(3). doi:10.1042/BSR20140021
  • Zanoni I, Granucci F. Role of CD14 in host protection against infections and in metabolism regulation. Front Cell Infect Microbiol. 2013;3:32. doi:10.3389/fcimb.2013.0003223898465
  • Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, Caballero-Olin G, Arce-Mendoza AY. CD14 C(−159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J Infect Dis. 2007;196(11):1698–1706. doi:10.1086/52214718008256
  • Lawn SD, Labeta MO, Arias M, Acheampong JW, Griffin GE. Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin Exp Immunol. 2000;120(3):483–487. doi:10.1046/j.1365-2249.2000.01246.x10844527
  • Wieland CW, van der Windt GJ, Wiersinga WJ, Florquin S, van der Poll T. CD14 contributes to pulmonary inflammation and mortality during murine tuberculosis. Immunology. 2008;125(2):272–279. doi:10.1111/j.1365-2567.2008.02840.x18393969
  • Heung LJ, Luberto C, Del Poeta M. Role of sphingolipids in microbial pathogenesis. Infect Immun. 2006;74(1):28–39. doi:10.1128/IAI.74.1.28-39.200616368954
  • Niekamp P, Guzman G, Leier H, et al. Sphingomyelin biosynthesis is critical in organizing phosphoinositide turnover during phagocytic uptake of Mycobacterium tuberculosis. bioRxiv. 2019;565226.
  • Cruz D, Watson AD, Miller CS, et al. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest. 2008;118(8):2917–2928. doi:10.1172/JCI3418918636118
  • Ramakrishnan K, Shenbagarathai R, Kavitha K, Thirumalaikolundusubramanian P, Rathinasabapati R. Selenium levels in persons with HIV/tuberculosis in India, Madurai City. Clin Lab. 2012;58(1–2):165–168.22372360
  • Grobler L, Nagpal S, Sudarsanam TD, Sinclair D. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev. 2016;6.
  • Lee J, Geddes K, Streutker C, Philpott DJ, Girardin SE. Role of mouse peptidoglycan recognition protein PGLYRP2 in the innate immune response to Salmonella enterica serovar Typhimurium infection in vivo. Infect Immun. 2012;80(8):2645–2654. doi:10.1128/IAI.00168-1222615249
  • Shi L, Jiang Q, Bushkin Y, Subbian S, Tyagi S, Garsin DA. Biphasic dynamics of macrophage immunometabolism during Mycobacterium tuberculosis Infection. MBio. 2019;10(2):2. doi:10.1128/mBio.02550-18